John C. Goodman

From WikiMD's Food, Medicine & Wellness Encyclopedia

John C. Goodman

John C. Goodman is an American economist known for his work in health economics, public policy, and the health care system in the United States. He is often referred to as the "Father of Health Savings Accounts" (HSAs), a title that underscores his pivotal role in the development and advocacy of consumer-directed health care. Goodman's contributions to health economics and policy have sparked considerable debate and have had a significant impact on health care reform efforts in the U.S.

Early Life and Education[edit | edit source]

John C. Goodman was born in Texas. He pursued his undergraduate studies at the University of Texas at Austin, where he received a Bachelor of Science degree. He went on to earn his Ph.D. in economics from Columbia University, focusing his research on the economics of public policy.

Career[edit | edit source]

After completing his education, Goodman founded the National Center for Policy Analysis (NCPA) in 1983, a think tank based in Dallas, Texas, that focuses on free-market approaches to public policy issues. Under Goodman's leadership, the NCPA became a prominent voice in national debates on health care, taxation, retirement, and environmental policies.

Goodman's work at the NCPA and his writings have extensively covered the inefficiencies and challenges within the U.S. health care system, advocating for a greater role of free markets and consumer choice in health care decisions. He has been a strong proponent of Health Savings Accounts, arguing that they empower consumers to make more informed health care choices, leading to better health outcomes and cost savings.

Contributions to Health Economics[edit | edit source]

John C. Goodman's most notable contribution to health economics is his advocacy for Health Savings Accounts. HSAs are tax-advantaged accounts that individuals can use to pay for qualified medical expenses. Goodman's argument is that by giving individuals more control over their health care spending, HSAs encourage consumers to seek value for their health care dollars, thus driving down costs and improving quality in the health care system.

Goodman has also contributed to the debate on health care reform in the United States, critiquing various proposals for their potential to limit consumer choice and increase government control over health care decisions. He has been a vocal critic of the Affordable Care Act, arguing that it does not address the fundamental issues of cost and quality in the health care system.

Publications[edit | edit source]

John C. Goodman has authored and co-authored several books and numerous articles on health care policy, economics, and other public policy issues. His works often emphasize the importance of free-market principles in addressing public policy challenges.

Legacy and Criticism[edit | edit source]

Goodman's advocacy for Health Savings Accounts and his broader work in health economics have been influential, contributing to the inclusion of HSAs in federal health policy. However, his views and proposals have also been subject to criticism, particularly from those who favor more government involvement in health care. Critics argue that HSAs and similar market-based approaches can lead to disparities in health care access and outcomes.

Conclusion[edit | edit source]

John C. Goodman's work in health economics and public policy has left a lasting impact on the debate over health care reform in the United States. His advocacy for Health Savings Accounts and consumer-directed health care has shaped policy discussions and influenced legislative outcomes. Despite the controversy that sometimes surrounds his proposals, Goodman's contributions to the field of health economics continue to provoke thoughtful discussion on the future of health care in the U.S.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD